L-2-amino-2-(4'-hydroxyphenyl)-N-methylacetamide | 168158-40-5

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: L-2-amino-2-(4'-hydroxyphenyl)-N-methylacetamide
• 英文别名: (2S)-2-amino-2-(4-hydroxyphenyl)-N-methylacetamide
• CAS: 168158-40-5
• 化学式: C₉H₁₂N₂O₂
• 分子量: 180.206
• InChiKey: HKZUAHXWBANDNM-QMMMGPOBSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0
• 重原子数：
  13
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  75.4
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  L-2-amino-2-(4'-hydroxyphenyl)-N-methylacetamide 在 4-二甲氨基吡啶 、 N-(2-Aminoethyl)aminomethyl polystyrene 作用下， 以 四氢呋喃 为溶剂， 生成 Benzo[1,3]dioxole-5-carboxylic acid [(S)-(4-hydroxy-phenyl)-methylcarbamoyl-methyl]-amide
  参考文献：
  名称：

  使用固相支持试剂全合成芳樟科生物碱（+）-三聚氰胺

  摘要：

  在本报告中，我们全面描述了芳科植物生物碱（+）-plicamine 1的总合成，包括模型化合物研究。在这两种情况下，使用固相支持的试剂和清除剂在多步反应序列中制备化合物，即可得到不需要常规纯化但可用于下一合成步骤的物质。

  DOI：

  10.1016/s0040-4020(02)00628-2
• 作为产物：
  描述：

  N-benzyloxycarbonyl-L-(p-hydroxyphenyl)glycine-N-methylamide 在 palladium on activated charcoal 氢气 作用下， 以 甲醇 为溶剂， 生成 L-2-amino-2-(4'-hydroxyphenyl)-N-methylacetamide
  参考文献：
  名称：

  Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors

  摘要：

  The synthesis and biological evaluation of orally active inhibitors of matrix metalloproteinase are reported. Modifications of the P2' position and the a-substituent of hydroxamic acid derivatives were carried out, and revealed that the P2' substituent influenced the MMP inhibitory activities in vitro and in plasma after oral administration. The hydroxamates with phenylglycine at the P2' position were absorbed well orally. Compound 15e, which exhibited the longest duration of inhibitory activity in plasma after oral administration among the phenylglycine derivatives (5a-5d, 15a, 15c, 15e), was evaluated in a rat adjuvant arthritis model. A reduction in hind foot pad swelling and improvements of some inflammatory parameters were demonstrated when the compound was administered orally. These results indicate the potential of MMP inhibitors for rheumatoid arthritis. (C) 1997 Elsevier Science Ltd.

  DOI：

  10.1016/s0968-0896(97)00028-x

文献信息

• Total Synthesis of the Amaryllidaceae Alkaloid (+)-Plicamine and Its Unnatural Enantiomer by Using Solid-Supported Reagents and Scavengers in a Multistep Sequence of Reactions We gratefully acknowledge financial support from Pfizer Central Research for a Postdoctoral Fellowship (to I.R.B.), the BP endowment and the Novartis Research Fellowship (to S.V.L.), and Pharmacia & Upjohn (to C.P.).
  作者：Ian R. Baxendale、Steven V. Ley、Claudia Piutti

  DOI：10.1002/1521-3773(20020617)41:12<2194::aid-anie2194>3.0.co;2-4

  日期：2002.6.17
• Total synthesis of the amaryllidaceae alkaloid (+)-plicamine using solid-supported reagents
  作者：Ian R Baxendale、Steven V Ley、Marcella Nessi、Claudia Piutti

  DOI：10.1016/s0040-4020(02)00628-2

  日期：2002.8

  In this report we describe in full the total synthesis of the amaryllidaceae alkaloid (+)-plicamine 1 including a model compound study. In both cases the compounds were prepared using solid-supported reagents and scavengers in multi-step sequences of reactions to give materials which required no conventional purification but could be carried on to the next synthetic step.

  在本报告中，我们全面描述了芳科植物生物碱（+）-plicamine 1的总合成，包括模型化合物研究。在这两种情况下，使用固相支持的试剂和清除剂在多步反应序列中制备化合物，即可得到不需要常规纯化但可用于下一合成步骤的物质。
• Synthesis and biological evaluation of orally active matrix metalloproteinase inhibitors
  作者：Ryoichi Hirayama、Minoru Yamamoto、Takahiro Tsukida、Konomi Matsuo、Yuji Obata、Fumio Sakamoto、Shoji Ikeda

  DOI：10.1016/s0968-0896(97)00028-x

  日期：1997.4

  The synthesis and biological evaluation of orally active inhibitors of matrix metalloproteinase are reported. Modifications of the P2' position and the a-substituent of hydroxamic acid derivatives were carried out, and revealed that the P2' substituent influenced the MMP inhibitory activities in vitro and in plasma after oral administration. The hydroxamates with phenylglycine at the P2' position were absorbed well orally. Compound 15e, which exhibited the longest duration of inhibitory activity in plasma after oral administration among the phenylglycine derivatives (5a-5d, 15a, 15c, 15e), was evaluated in a rat adjuvant arthritis model. A reduction in hind foot pad swelling and improvements of some inflammatory parameters were demonstrated when the compound was administered orally. These results indicate the potential of MMP inhibitors for rheumatoid arthritis. (C) 1997 Elsevier Science Ltd.